Literature DB >> 10752684

Basement membrane laminin-5 is deposited in colorectal adenomas and carcinomas and serves as a ligand for alpha3beta1 integrin.

J Lohi1, J Oivula, E Kivilaakso, T Kiviluoto, K Fröjdman, Y Yamada, R E Burgeson, I Leivo, I Virtanen.   

Abstract

Interplay between laminin-5 (Ln-5) and its integrin (Int) receptors alpha2beta1, alpha3beta1 and alpha6beta4 has been implicated in the progression and invasion of carcinomas. In this study we found abundant immunoreactivity for chains of Ln-5 (alpha3-beta3-gamma2) and Ln-10 (alpha5-beta1-gamma1), as well as for type VII collagen, in basement membranes (BM) of colorectal adenomas. In carcinomas of all differentiation grades, Lns were seen in tumor BMs, whereas type VII collagen was almost absent. Ln-5 appeared to accumulate along the invading edges of carcinomas, while Ln-10 was mostly absent. Immunoreactivity for Ln al chain, a component of Lns-1 and -3, was not seen in adenomas or carcinomas. Immunoreactivity for alpha2, alpha6, beta1 and beta4 Ints was found in all tumors and that for alpha3 Int in all adenomas and most of the carcinomas, often in colocalization with Ln-5. Immunoblotting of carcinoma tissues showed that the gamma2 chain of Ln-5 was present as typical Mr 105000 and 155000 isoforms. Immunoprecipitation experiments showed production of Ln-5 by cultured colon carcinoma cells. In quantitative cell adhesion experiments, function-blocking MAbs to alpha3 and beta1 Int subunits, but not those to Int alpha2 or alpha6 subunits, significantly inhibited the adhesion of cells to Ln-5. Our results suggest that BM composition in colorectal adenomas reflects the properties of surface epithelial BM of colorectal mucosa. In invading carcinomas, trimeric Ln-5, produced by carcinoma cells, is a major BM component and the cells use the alpha3beta1 Int complex for adhesion to Ln-5.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752684     DOI: 10.1034/j.1600-0463.2000.d01-40.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  17 in total

1.  Differential expression of the integrins alpha6Abeta4 and alpha6Bbeta4 along the crypt-villus axis in the human small intestine.

Authors:  Anders Bondo Dydensborg; Inga C Teller; Nuria Basora; Jean-François Groulx; Joëlle Auclair; Caroline Francoeur; Fabrice Escaffit; Fréderic Paré; Elizabeth Herring; Daniel Ménard; Jean-François Beaulieu
Journal:  Histochem Cell Biol       Date:  2008-12-24       Impact factor: 4.304

Review 2.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

3.  Integrin α6β4 in colorectal cancer.

Authors:  Jean-François Beaulieu
Journal:  World J Gastrointest Pathophysiol       Date:  2010-04-15

Review 4.  Assembly, heterogeneity, and breaching of the basement membranes.

Authors:  Alexandros Glentis; Vasily Gurchenkov; Danijela Matic Vignjevic
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

5.  Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.

Authors:  John M Lamar; Vandana Iyer; C Michael DiPersio
Journal:  J Invest Dermatol       Date:  2007-08-30       Impact factor: 8.551

Review 6.  Laminin-5 in epithelial tumour invasion.

Authors:  Masahiko Katayama; Kiyotoshi Sekiguchi
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

7.  Epithelial-mesenchymal transition downregulates laminin alpha5 chain and upregulates laminin alpha4 chain in oral squamous carcinoma cells.

Authors:  Minna Takkunen; Mari Ainola; Noora Vainionpää; Reidar Grenman; Manuel Patarroyo; Antonio García de Herreros; Yrjö T Konttinen; Ismo Virtanen
Journal:  Histochem Cell Biol       Date:  2008-05-22       Impact factor: 4.304

8.  LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.

Authors:  Zhehui Zhu; Jinglue Song; Yuegui Guo; Zhenyu Huang; Xiaojian Chen; Xuening Dang; Yuji Huang; Yuhan Wang; Weijun Ou; Yili Yang; Wei Yu; Chen-Ying Liu; Long Cui
Journal:  Oncogene       Date:  2020-05-12       Impact factor: 9.867

Review 9.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

10.  Integrin alpha6Bbeta4 inhibits colon cancer cell proliferation and c-Myc activity.

Authors:  Anders Bondo Dydensborg; Inga C Teller; Jean-François Groulx; Nuria Basora; Fréderic Paré; Elizabeth Herring; Rémy Gauthier; Dominique Jean; Jean-François Beaulieu
Journal:  BMC Cancer       Date:  2009-07-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.